Search results

Applications, Recent results, Publications.

This National Science Week, we're acknowledging the 2026 theme, “Seeds of Science: Nurturing knowledge for all” by celebrating the ideas, facilities and people that help scientific knowledge flourish with a series of activities.

The Australian Synchrotron provides funding support for successful beamtime applicants in the form of travel funding and/or onsite accommodation. Travel funds granted are to be used solely to cover the majority of the cost to travel to the AS facility. The User Office will book accommodation for interstate user groups at the onsite AS Guesthouse.

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.

ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.

ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.

Ready to start a hands-on career? ANSTO’s Apprenticeship Program gives you the chance to earn while you learn, build real trade skills and contribute to work that supports Australia’s leading nuclear science and technology organisation.

The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

ANSTO is interested finding students to collaborate on Generation IV reactor systems.

The Medium Energy- X-ray Absorption Spectroscopy beamlines provides access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.